176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.96%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.66%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-23.85%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-23.85%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-30.62%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-31.82%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-31.82%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.89%
Slight or no buybacks while MU is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.05%
Slight or no buyback while MU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-1.35%
Dividend reduction while MU stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-44.44%
Negative OCF growth while MU is at 8.74%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-47.53%
Negative FCF growth while MU is at 117.69%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
81.68%
10Y revenue/share CAGR 1.25-1.5x MU's 54.52%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
18.70%
5Y revenue/share CAGR under 50% of MU's 39.83%. Michael Burry would suspect a significant competitive gap or product weakness.
39.59%
3Y revenue/share CAGR at 50-75% of MU's 78.90%. Martin Whitman would question if the firm lags behind competitor innovations.
153.08%
10Y OCF/share CAGR above 1.5x MU's 65.45%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
4809.05%
5Y OCF/share CAGR above 1.5x MU's 43.83%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
3096.56%
3Y OCF/share CAGR above 1.5x MU's 364.81%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
91.62%
Net income/share CAGR at 75-90% of MU's 106.70%. Bill Ackman would press for strategic moves to boost long-term earnings.
0.61%
Below 50% of MU's 24.93%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
148.69%
3Y net income/share CAGR 75-90% of MU's 173.37%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
241.19%
10Y equity/share CAGR above 1.5x MU's 30.44%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
64.54%
5Y equity/share CAGR above 1.5x MU's 40.57%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
19.19%
Below 50% of MU's 61.30%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.01%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-9.30%
Inventory is declining while MU stands at 4.06%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.24%
Asset growth 1.25-1.5x MU's 1.01%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
2.22%
BV/share growth of 2.22% while MU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
0.40%
Debt growth far above MU's 0.39%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.66%
Our R&D shrinks while MU invests at 11.08%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
14.80%
SG&A growth well above MU's 5.29%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.